RxDB
ICD-10-PCS Codes Browse (Tables)

ICD-10 PCS – Browse (Tables)

Code Title
– Top Categories
3 Administration
3E Physiological Systems and Anatomical Regions
3E0 Introduction Administration, Physiological Systems and Anatomical Regions, Introduction
3E03 Peripheral Vein
3E030 Open
3E0300 Antineoplastic
3E03002 High-dose Interleukin-2 Introduction of High-dose Interleukin-2 into Peripheral Vein, Open Approach
3E03003 Low-dose Interleukin-2 Introduction of Low-dose Interleukin-2 into Peripheral Vein, Open Approach
3E03005 Other Antineoplastic Introduction of Other Antineoplastic into Peripheral Vein, Open Approach
3E0300M Monoclonal Antibody Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Vein, Open Approach
3E0300P Clofarabine Introduction of Clofarabine into Peripheral Vein, Open Approach
3E0301 Thrombolytic
3E03016 Recombinant Human-activated Protein C Introduction of Recombinant Human-activated Protein C into Peripheral Vein, Open
3E03017 Other Thrombolytic Introduction of Other Thrombolytic into Peripheral Vein, Open Approach
3E0302 Anti-infective
3E03028 Oxazolidinones Introduction of Oxazolidinones into Peripheral Vein, Open Approach
3E03029 Other Anti-infective Introduction of Other Anti-infective into Peripheral Vein, Open Approach
3E0303 Anti-inflammatory
3E0303Z No Qualifier Introduction of Anti-inflammatory into Peripheral Vein, Open Approach
3E0304 Serum, Toxoid and Vaccine
3E0304Z No Qualifier Introduction of Serum, Toxoid and Vaccine into Peripheral Vein, Open Approach
3E0306 Nutritional Substance
3E0306Z No Qualifier Introduction of Nutritional Substance into Peripheral Vein, Open Approach
3E0307 Electrolytic and Water Balance Substance
3E0307Z No Qualifier Introduction of Electrolytic and Water Balance Substance into Peripheral Vein, Open Approach
3E030F Intracirculatory Anesthetic
3E030FZ No Qualifier Introduction of Intracirculatory Anesthetic into Peripheral Vein, Open Approach
3E030G Other Therapeutic Substance
3E030GC Other Substance Introduction of Other Therapeutic Substance into Peripheral Vein, Open Approach
3E030GN Blood Brain Barrier Disruption Introduction of Blood Brain Barrier Disruption Substance into Peripheral Vein, Open Approach
3E030H Radioactive Substance
3E030HZ No Qualifier Introduction of Radioactive Substance into Peripheral Vein, Open Approach
3E030K Other Diagnostic Substance
3E030KZ No Qualifier Introduction of Other Diagnostic Substance into Peripheral Vein, Open Approach
3E030N Analgesics, Hypnotics, Sedatives
3E030NZ No Qualifier Introduction of Analgesics, Hypnotics, Sedatives into Peripheral Vein, Open Approach
3E030P Platelet Inhibitor
3E030PZ No Qualifier Introduction of Platelet Inhibitor into Peripheral Vein, Open Approach
3E030R Antiarrhythmic
3E030RZ No Qualifier Introduction of Antiarrhythmic into Peripheral Vein, Open Approach
3E030T Destructive Agent
3E030TZ No Qualifier Introduction of Destructive Agent into Peripheral Vein, Open Approach
3E030U Pancreatic Islet Cells
3E030U0 Autologous Introduction of Autologous Pancreatic Islet Cells into Peripheral Vein, Open Approach
3E030U1 Nonautologous Introduction of Nonautologous Pancreatic Islet Cells into Peripheral Vein, Open Approach
3E030V Hormone
3E030VG Insulin Introduction of Insulin into Peripheral Vein, Open Approach
3E030VH Human B-type Natriuretic Peptide Introduction of Human B-type Natriuretic Peptide into Peripheral Vein, Open Approach
3E030VJ Other Hormone Introduction of Other Hormone into Peripheral Vein, Open Approach
3E030W Immunotherapeutic
3E030WK Immunostimulator Introduction of Immunostimulator into Peripheral Vein, Open
3E030WL Immunosuppressive Introduction of Immunosuppressive into Peripheral Vein, Open
3E030X Vasopressor
3E030XZ No Qualifier Introduction of Vasopressor into Peripheral Vein, Open Approach
3E033 Percutaneous
3E0330 Antineoplastic
3E03302 High-dose Interleukin-2 Introduction of High-dose Interleukin-2 into Peripheral Vein, Percutaneous Approach
3E03303 Low-dose Interleukin-2 Introduction of Low-dose Interleukin-2 into Peripheral Vein, Percutaneous Approach
3E03305 Other Antineoplastic Introduction of Other Antineoplastic into Peripheral Vein, Percutaneous Approach
3E0330M Monoclonal Antibody Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Vein, Percutaneous Approach
3E0330P Clofarabine Introduction of Clofarabine into Peripheral Vein, Percutaneous Approach
3E0331 Thrombolytic
3E03316 Recombinant Human-activated Protein C Introduction of Recombinant Human-activated Protein C into Peripheral Vein, Percutaneous
3E03317 Other Thrombolytic Introduction of Other Thrombolytic into Peripheral Vein, Percutaneous Approach
3E0332 Anti-infective
3E03328 Oxazolidinones Introduction of Oxazolidinones into Peripheral Vein, Percutaneous Approach
3E03329 Other Anti-infective Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach
3E0333 Anti-inflammatory
3E0333Z No Qualifier Introduction of Anti-inflammatory into Peripheral Vein, Percutaneous Approach
3E0334 Serum, Toxoid and Vaccine
3E0334Z No Qualifier Introduction of Serum, Toxoid and Vaccine into Peripheral Vein, Percutaneous Approach
3E0336 Nutritional Substance
3E0336Z No Qualifier Introduction of Nutritional Substance into Peripheral Vein, Percutaneous Approach
3E0337 Electrolytic and Water Balance Substance
3E0337Z No Qualifier Introduction of Electrolytic and Water Balance Substance into Peripheral Vein, Percutaneous Approach
3E033F Intracirculatory Anesthetic
3E033FZ No Qualifier Introduction of Intracirculatory Anesthetic into Peripheral Vein, Percutaneous Approach
3E033G Other Therapeutic Substance
3E033GC Other Substance Introduction of Other Therapeutic Substance into Peripheral Vein, Percutaneous Approach
3E033GN Blood Brain Barrier Disruption Introduction of Blood Brain Barrier Disruption Substance into Peripheral Vein, Percutaneous Approach
3E033GQ Glucarpidase Introduction of Glucarpidase into Peripheral Vein, Percutaneous Approach
3E033H Radioactive Substance
3E033HZ No Qualifier Introduction of Radioactive Substance into Peripheral Vein, Percutaneous Approach
3E033K Other Diagnostic Substance
3E033KZ No Qualifier Introduction of Other Diagnostic Substance into Peripheral Vein, Percutaneous Approach
3E033N Analgesics, Hypnotics, Sedatives
3E033NZ No Qualifier Introduction of Analgesics, Hypnotics, Sedatives into Peripheral Vein, Percutaneous Approach
3E033P Platelet Inhibitor
3E033PZ No Qualifier Introduction of Platelet Inhibitor into Peripheral Vein, Percutaneous Approach
3E033R Antiarrhythmic
3E033RZ No Qualifier Introduction of Antiarrhythmic into Peripheral Vein, Percutaneous Approach
3E033T Destructive Agent
3E033TZ No Qualifier Introduction of Destructive Agent into Peripheral Vein, Percutaneous Approach
3E033U Pancreatic Islet Cells
3E033U0 Autologous Introduction of Autologous Pancreatic Islet Cells into Peripheral Vein, Percutaneous Approach
3E033U1 Nonautologous Introduction of Nonautologous Pancreatic Islet Cells into Peripheral Vein, Percutaneous Approach
3E033V Hormone
3E033VG Insulin Introduction of Insulin into Peripheral Vein, Percutaneous Approach
3E033VH Human B-type Natriuretic Peptide Introduction of Human B-type Natriuretic Peptide into Peripheral Vein, Percutaneous Approach
3E033VJ Other Hormone Introduction of Other Hormone into Peripheral Vein, Percutaneous Approach
3E033W Immunotherapeutic
3E033WK Immunostimulator Introduction of Immunostimulator into Peripheral Vein, Percutaneous
3E033WL Immunosuppressive Introduction of Immunosuppressive into Peripheral Vein, Percutaneous
3E033X Vasopressor
3E033XZ No Qualifier Introduction of Vasopressor into Peripheral Vein, Percutaneous Approach